Concepedia

Florin Draica

FD

Statistics

Publications

5

Citations

98

H-Index

5

Active since

2022

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Pfizer (France)

Florin Draica is an author at Pfizer (United States) specializing in pharmacy, infectious diseases, and pharmacoeconomics.

ORCID

Publications per year

2022–2024

5

Publications

5

Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19

Amie Scott, Wajeeha Ansari, Farid Khan et al. · BMC Medicine · 2024 · 24 citations · Full text

, , +17

Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States

Josh J. Carlson, V. Foos, Adam Kasle et al. · Value in Health · 2023 · 23 citations · Full text

, , +11

Real-World Evidence of the Top 100 Prescribed Drugs in the USA and Their Potential for Drug Interactions with Nirmatrelvir; Ritonavir

Jacqueline Gerhart, Florin Draica, Michael Benigno et al. · The AAPS Journal · 2023 · 19 citations · Full text

, , +17

Substantial health and economic burden of COVID-19 during the year after acute illness among US adults not at high risk of severe COVID-19

Amie Scott, Wajeeha Ansari, Richard Chambers et al. · BMC Medicine · 2024 · 18 citations · Full text

, , +15

Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United States

Amie Scott, Richard Chambers, Maya Reimbaeva et al. · Journal of Medical Economics · 2022 · 14 citations · Full text

, , +12

1–5 of 5